William Resides
Director Ejecutivo en FINDIT .
Cargos activos de William Resides
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FINDIT | Director/Miembro de la Junta | 08/03/2024 | - |
| Director Ejecutivo | 08/03/2024 | - | |
| Director Financiero/CFO | 08/03/2024 | - |
Historial de carrera de William Resides
Antiguos cargos conocidos de William Resides.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
NuLife Sciences, Inc.
 NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Director Ejecutivo | 02/01/2019 | - |
| Fundador | 02/01/2019 | - | |
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
| Fundador | - | - |
Estadísticas
Internacional
| Estados Unidos | 4 |
Operativa
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Sectorial
| Health Technology | 2 |
| Technology Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FINDIT | Technology Services |
| Empresas privadas | 2 |
|---|---|
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- William Resides
- Experiencia